Literature DB >> 16198339

Enhancer-specified GFP-based FACS purification of human spinal motor neurons from embryonic stem cells.

Neeta Singh Roy1, Takahiro Nakano, Li Xuing, Jian Kang, Maiken Nedergaard, Steven A Goldman.   

Abstract

Human embryonic stem (hES) cells may generate all major somatic cell types, yet no neuronal subtype has yet been specifically generated in useful purity from hES culture. We report here the selective induction and isolation of functional spinal motor neurons (MNs) from human ES cells. hES cells of the H1 line were transfected with plasmids encoding GFP placed under the control of an MN-specifying enhancer within the 5'-regulatory region of the gene encoding the transcription factor Hb9 and treated with sonic hedgehog (Shh) and retinoic acid (RA). As MNs were induced under the influence of Shh and RA, they activated Hb9-driven GFP expression, permitting their isolation by fluorescence-activated cell sorting (FACS). The MNs thereby generated and isolated became cholinergic and achieved functional maturation in vitro, as evidenced by their fast sodium currents and action potentials on whole-cell patch-clamp and alpha-bungarotoxin-identified clustering of AChR receptors on co-cultured skeletal myoblasts. The serial combination of these two approaches, motor neuron phenotypic induction followed by Hb9 enhancer-based FACS, permitted the high-efficiency induction and isolation of functional motor neurons from hES cells. These results suggest the utility of promoter/enhancer-based FACS for the isolation of specific phenotypes from hES cell populations as a means of purifying clinically appropriate vectors for cell therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16198339     DOI: 10.1016/j.expneurol.2005.06.021

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  71 in total

1.  Human stem cells as a model of motoneuron development and diseases.

Authors:  Yan Liu; Su-Chun Zhang
Journal:  Ann N Y Acad Sci       Date:  2010-06       Impact factor: 5.691

Review 2.  Using human pluripotent stem cells to untangle neurodegenerative disease mechanisms.

Authors:  Brigitte Malgrange; Laurence Borgs; Benjamin Grobarczyk; Audrey Purnelle; Patricia Ernst; Gustave Moonen; Laurent Nguyen
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

Review 3.  Human motor neuron generation from embryonic stem cells and induced pluripotent stem cells.

Authors:  M Nizzardo; C Simone; M Falcone; F Locatelli; G Riboldi; G P Comi; S Corti
Journal:  Cell Mol Life Sci       Date:  2010-07-29       Impact factor: 9.261

Review 4.  Stem cell-based models and therapies for neurodegenerative diseases.

Authors:  Shilpa Iyer; Khaled Alsayegh; Sheena Abraham; Raj R Rao
Journal:  Crit Rev Biomed Eng       Date:  2009

5.  Directed differentiation of neural-stem cells and subtype-specific neurons from hESCs.

Authors:  Bao-Yang Hu; Su-Chun Zhang
Journal:  Methods Mol Biol       Date:  2010

Review 6.  Development and differentiation of neural rosettes derived from human embryonic stem cells.

Authors:  Patricia G Wilson; Steve S Stice
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

7.  Functional neural development from human embryonic stem cells: accelerated synaptic activity via astrocyte coculture.

Authors:  M Austin Johnson; Jason P Weick; Robert A Pearce; Su-Chun Zhang
Journal:  J Neurosci       Date:  2007-03-21       Impact factor: 6.167

Review 8.  Genetic modification of human embryonic stem cells.

Authors:  Xiaofeng Xia; Su-Chun Zhang
Journal:  Biotechnol Genet Eng Rev       Date:  2007

9.  Coordination of sonic hedgehog and Wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells.

Authors:  Xue-Jun Li; Xiaoqing Zhang; M Austin Johnson; Zhi-Bo Wang; Timothy Lavaute; Su-Chun Zhang
Journal:  Development       Date:  2009-12       Impact factor: 6.868

Review 10.  Stem cells in human neurodegenerative disorders--time for clinical translation?

Authors:  Olle Lindvall; Zaal Kokaia
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.